* BIOLASE Inc BIOL.OQ reported a quarterly adjusted loss of 2
cents per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss of 4
cents per share.
* Revenue rose 210.9% to $9.13 million from a year ago;
analysts expected $8.31 million.
* BIOLASE Inc's reported EPS for the quarter was breakeven
results.
* The mean earnings estimate of analysts had fallen by
about 8.3% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* BIOLASE Inc shares had fallen by 9.8% this quarter and
gained 51.2% so far this year.
* The company reported a quarterly loss of $708 thousand.
* Wall Street's median 12-month price target for BIOLASE Inc is
$2.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated August 12 at 10:14 p.m. All
figures in US dollars unless otherwise stated